Cuba highlights results of liver and ovary cancer vaccine
por Cuban Biotechnological and Pharmaceutical Industries (Biocubafarma) Business Group highlighted on Tuesday, the new clinical evidence of safety and therapeutic effect of the national vaccine HeberSaVax, which represented an achievement of science and innovation in 2022 in the country.
por